PCAVANZ Stock Latest News
Private CompaniesAvanzanite Bioscience Strengthens UK Operations With New Country Manager5d agoAVANZ
Private CompaniesAvanzanite Bioscience Targets Visibility at Major European Orphan Drug Congress1w agoAVANZ
Private CompaniesAvanzanite Bioscience Expands Business Development Footprint with North American Hire1w agoAVANZ
Private CompaniesAvanzanite Bioscience Highlights Support for Acanthamoeba Keratitis Patient Advocacy1w agoAVANZ
Private CompaniesAvanzanite Bioscience Targets Market Access Gaps in European Rare Diseases1w agoAVANZPrivate CompaniesAvanzanite Bioscience Expands European Rare-Disease Commercial Infrastructure2w agoAVANZ
Private CompaniesAvanzanite Bioscience Invests in ERP Capabilities Amid European Expansion2w agoAVANZ
Private CompaniesAvanzanite Bioscience Expands European Rare-Disease Workforce2w agoAVANZ
Private CompaniesAvanzanite Bioscience Highlights Engagement at ASCAT 2026 Haematology Conference2w agoAVANZ
Private CompaniesAvanzanite Bioscience Highlights Strategic Presence at ASCAT 2026 Conference3w agoAVANZ
Private CompaniesAvanzanite Bioscience Highlights Philanthropic Engagement in Rare Disease Community3w agoAVANZPrivate CompaniesAvanzanite Bioscience Positions Pan-European Model for Rare-Disease Market Access1M agoAVANZ
Private CompaniesAvanzanite Bioscience Sponsors New Mediterranean Haemoglobinopathy Network1M agoAVANZ
Private CompaniesRare Disease Event Underscores Avanzanite Bioscience’s Strategic Focus1M agoAVANZ
Private CompaniesAvanzanite Bioscience Highlights Rome-Based Knights for Rare 2026 Fundraising Event2M agoAVANZ
Private CompaniesAvanzanite Bioscience Strengthens Data and ERP Capabilities Amid European Expansion2M agoAVANZ


